Related Experiment Video
Updated: May 21, 2026

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra
Published on: September 8, 2021
Polyunsaturated fatty acids and their metabolites in the pathobiology of schizophrenia
1UND Life Sciences, 13800 Fairhill Road, Shaker Heights, OH 44120, USA. undurti@hotmail.com
Insights
Schizophrenia may stem from perinatal inflammation, potentially treatable with polyunsaturated fatty acids (PUFAs). Supplementing PUFAs during development and adulthood could prevent and treat this condition.
Area of Science:
- Neuroscience
- Immunology
- Nutritional Psychiatry
Background:
- Schizophrenia is proposed as a low-grade systemic inflammatory disease originating in the perinatal period.
- Genetic, environmental, and nutritional factors may interact to increase pro-inflammatory cytokines, damaging fetal neurons and leading to adult-onset schizophrenia.
Purpose of the Study:
- To explore the role of polyunsaturated fatty acids (PUFAs) in schizophrenia.
- To investigate PUFAs' neuroprotective and anti-inflammatory mechanisms.
- To assess the potential of PUFA supplementation in schizophrenia prevention and treatment.
Main Methods:
- Literature review and theoretical proposal.
- Analysis of the biochemical pathways involving PUFAs and pro-inflammatory cytokines.
- Examination of the impact of desaturase enzyme activity on PUFA metabolism.
Main Results:
- PUFAs and their metabolites exhibit neuroprotective and anti-inflammatory properties, inhibiting pro-inflammatory cytokine production.
- Reduced PUFA formation due to low desaturase activity may increase inflammation and neuronal damage, predisposing to schizophrenia.
- PUFAs are crucial for brain development, suggesting a role in schizophrenia etiology.
Conclusions:
- Perinatal and adult PUFA supplementation may prevent and treat schizophrenia.
- Synthetic analogs of PUFA metabolites could offer therapeutic benefits for schizophrenia.
- Addressing PUFA metabolism and inflammation presents a novel therapeutic strategy for schizophrenia.
Abstract:
Schizophrenia can be considered as a low-grade systemic inflammatory disease with its origins in the perinatal period. It is likely that genetic, environmental, and nutritional factors interact to induce excess production of pro-inflammatory cytokines that, in turn, damage fetal neurons leading to the adult onset of schizophrenia. Polyunsaturated fatty acids (PUFAs) and their metabolites such as lipoxins, resolvins, protectins, maresins and nitrolipids not only have potent neuroprotective action but also are capable of inhibiting the production of pro-inflammatory cytokines. Decreased formation of PUFAs as a result of low activity of Δ(6) and Δ(5) desaturases can result in an increase in the production of pro-inflammatory cytokines due to the absence of negative control exerted by PUFAs and their anti-inflammatory metabolites that, in turn, may predispose to neuronal damage and development of schizophrenia in adult life. Furthermore, PUFAs are essential for brain growth and development. If this proposal is correct, this implies that perinatal and adult supplementation of PUFAs not only prevents but also helps in the treatment of schizophrenia. Furthermore, synthetic analogs of lipoxins, resolvins, and protectins may be of significant benefit in schizophrenia.
Related Concept Videos
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Biological Causes of Schizophrenia
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
Psychological and Sociocultural Causes of Schizophrenia
Psychosis and Antipsychotic Drugs: Overview
Negative and Cognitive Symptoms of Schizophrenia
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Structure of Lipids
